APA (7th ed.) Citation

NP, W., AR, N., JF, S., YY, C., AV, M., RA, M., . . . SM, K. (2023). A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern. The Journal of infectious diseases, 228(5), 555. https://doi.org/10.1093/infdis/jiad102

Chicago Style (17th ed.) Citation

NP, Wayham, et al. "A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern." The Journal of Infectious Diseases 228, no. 5 (2023): 555. https://doi.org/10.1093/infdis/jiad102.

MLA (9th ed.) Citation

NP, Wayham, et al. "A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern." The Journal of Infectious Diseases, vol. 228, no. 5, 2023, p. 555, https://doi.org/10.1093/infdis/jiad102.